Show Summary Details
Page of

Cardioprotective drug therapies 

Cardioprotective drug therapies
Chapter:
Cardioprotective drug therapies
Author(s):

C.S. Jennings

, A.C. Mead

, J.L. Jones

, A.M. Holden

, S.B. Connolly

, K. Kotseva

, and D.A. Wood

DOI:
10.1093/med/9780199236305.003.0011
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2020

Antiplatelet therapy 194

Beta-blockers 194

ACE inhibitors 194

Lipid lowering therapies 194

Calcium-channel blockers 194

Diuretics 194

Anticoagulation 195

All with established CVD (including diabetics) unless contraindicated; lifelong treatment with a low dose (75–150 mg daily) is recommended.

Asymptomatic individuals, aspirin should only be con-sidered when the 10-year risk of CVD mortality is mark-edly increased and the BP is controlled....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.